English

Immunotherapy in Breast Cancer | Dr. Poonam Patil | Manipal Hospital Old Airport Road

Immunotherapy is transforming the way breast cancer is treated by harnessing the body’s own immune system to fight cancer cells. Advanced drugs like Trastuzumab, Pertuzumab, Trastuzumab Deruxtecan, and T-DM1 target the HER2 receptor, while Pembrolizumab and Atezolizumab are used in triple-negative breast cancers to enhance treatment response. These targeted procedures help control disease progression and improve patient outcomes. Testing for HER2 and PD-L1 receptors plays a key role in determining the right therapy, ensuring a more personalised and effective approach to breast cancer treatment.